Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
1.
Braz. j. med. biol. res ; 53(6): e9489, 2020. graf
Article Dans Anglais | LILACS, ColecionaSUS | ID: biblio-1132521

Résumé

Rheumatoid arthritis (RA) is an autoimmune disease of knee joints involving pain and inflammation. Rhoifolin is a plant flavonoid known to have antioxidant and anti-inflammatory properties. This study was taken to identify the effect of rhoifolin on complete Freund's adjuvant (CFA)-induced arthritis in the rat model. Treatment with rhoifolin (10 and 20 mg/kg) showed a significant improvement in the overall health parameters such as paw edema and weight loss. This improvement in morphological parameters corroborated the findings with gross morphological changes observed in the histopathological analysis. Rhoifolin treatment also caused a significant decrease in oxidative stress, evident from changes in intracellular levels of glutathione, glutathione peroxidase, malondialdehyde, and superoxide dismutase in the articular cartilage tissue. Moreover, proinflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin(IL)-1β, and IL-6 showed a significant downregulation of gene expression and intracellular protein concentration levels. The NF-κB pathway showed a significant attenuation as evident in the significant reduction in the levels of NF-κB p65 and p-IκB-α. These results indicated that rhoifolin can be a natural therapeutic alternative to the extant regimens, which include non-steroidal anti-inflammatory drugs and immunosuppressants. Additionally, the antioxidant and anti-inflammatory action of rhoifolin was probably mediated by the NF-κB pathway. However, the exact target molecules of this pathway need to be determined in further studies.


Sujets)
Animaux , Mâle , Rats , Arthrite expérimentale/traitement médicamenteux , Polyarthrite rhumatoïde/traitement médicamenteux , Flavonoïdes/administration et posologie , Adjuvant Freund/administration et posologie , Cytokines/sang , Stress oxydatif/effets des médicaments et des substances chimiques , Diholoside/administration et posologie , Arthrite expérimentale/métabolisme , Polyarthrite rhumatoïde/métabolisme , Marqueurs biologiques/sang , Facteur de transcription NF-kappa B/effets des médicaments et des substances chimiques , Facteur de transcription NF-kappa B/métabolisme , Interleukine-6/sang , Facteur de nécrose tumorale alpha/sang , Interleukine-1 bêta/sang , Hétérosides/administration et posologie
2.
Journal of Veterinary Science ; : 115-119, 2011.
Article Dans Anglais | WPRIM | ID: wpr-148005

Résumé

The isoflavonol glycoside Talosin A, genistein (GT)-7-alpha-L-6-deoxy talopyranose (GT-Tal), was first isolated from the culture broth of Kitasatospora kifunensis MJM341. The aim of the present study was to evaluate the oral absorption and metabolism of the newly isolated isoflavonol glycoside, GT-Tal compared to genistin (GT-7-O-beta-D-glucopyranoside; GT-Glu). Free GT-Glu and GT-Tal could not be detected prior to enzymatic hydrolysis of the corresponding conjugates in rat plasma. Following oral administration of GT-Tal (15 min), GT-Tal was rapidly absorbed through the gastrointestinal tract and metabolized into GT-Tal conjugates with a mean Cmax of 2.74 microg/mL. GT-Tal was further metabolized to its aglycone, free GT and conjugated GT. After oral administration, GT-Glu was absorbed after being convereted to its aglycone and then further metabolized into its conjugate metabolites (free GT with a mean Cmax of 0.24 mg/mL at 1.25 h; conjugated GT with a mean Cmax of 1.31 mg/mL at 2.00 h). Significant differences in absorption and metabolism of GT-Tal and GT-Glu were observed. GT-Tal was metabolized into its corresponding conjugates or underwent deglycosylation to form GT, whereas GT-Glu was metabolized into its aglycone, GT.


Sujets)
Animaux , Mâle , Rats , Actinobacteria/composition chimique , Administration par voie orale , Aire sous la courbe , Hétérosides/administration et posologie , Hydrolyse , Absorption intestinale , Isoflavones/administration et posologie , Répartition aléatoire , Rat Sprague-Dawley
3.
Indian J Exp Biol ; 2005 Dec; 43(12): 1156-60
Article Dans Anglais | IMSEAR | ID: sea-56346

Résumé

The ethanolic extracts, various fractions and two pure compounds isolated from the plant N. arbortris were tested against Encephalomyocarditis Virus (EMCV) and Semliki Forest Virus (SFV). Pronounced in vitro virus inhibitory activity was observed with the ethanolic and n-butanol fractions as well as with the pure compounds arbortristoside A and arbortristoside C. In addition, ethanolic extracts and n-butanol fraction protected EMCV infected mice to the extent of 40 and 60% respectively against SFV at a daily dose of 125 mg/kg body weight.


Sujets)
Butan-1-ol/administration et posologie , Administration par voie orale , Infections à alphavirus/traitement médicamenteux , Animaux , Infections à cardiovirus/traitement médicamenteux , Chlorocebus aethiops , Relation dose-effet des médicaments , Virus de l'encéphalomyocardite/effets des médicaments et des substances chimiques , Hétérosides/administration et posologie , Injections péritoneales , Iridoïdes/administration et posologie , Souris , Oleaceae , Phytothérapie/méthodes , Extraits de plantes/pharmacologie , Graines , Virus de la forêt de Semliki/effets des médicaments et des substances chimiques , Cellules Vero
4.
Hindustan Antibiot Bull ; 2005-2006; 47-48(): 13-9
Article Dans Anglais | IMSEAR | ID: sea-2280

Résumé

The effect of Picroliv on hepatic microsomal mixed-function oxidases (MFO) and glutathione conjugating enzyme system in cholestatic rats was studied. Bile duct ligation in male rats for one weeks caused significant increase in both serum sorbitol dehydrogenase activity and serum bile acide concentration indicating cholestatic liver injury. Furthermore, a rise in the hepatic hydroxyproline level indicating collagen accumulation was observed. As a result of these alterations, the hepatic microsomal MFO system was imparied as evidenced by a decrease in cytochrome P-450 system content and in the activities of NADPH-cytochrome C reductase and aminopyrine demethylase. While the hepatic glutathione content remained unaffected, the cytosolic glutathione S-transferase activity was clearly suppressed due to subchronic cholestasis. Oral administration of Picroliv (25 mg/kg/day for 21 days)--a standardized irioid glycoside fraction of Picrorhiza kurroa in bile ligation induced cholestatic rats, singnificantly prevented the biochemical changes induced in liver and serum of cholestatic rats. These results suggested that picroliv has anti-cholestatic activity which may be attributed to antioxidant property or it's specific role in protein synthesis.


Sujets)
Animaux , Antioxydants/métabolisme , Cholestase/enzymologie , Cinnamates/administration et posologie , Glutathion/analyse , Hétérosides/administration et posologie , Mâle , Microsomes du foie/effets des médicaments et des substances chimiques , Mixed function oxygenases/effets des médicaments et des substances chimiques , Rats , Acide vanillique/administration et posologie
SÉLECTION CITATIONS
Détails de la recherche